Latest webfg news

AstraZeneca to invest $2bn in Summit Therapeutics	29 Sept
Astrazeneca's Trixeo Aerosphere secures EU approval	23 Sept
Astrazeneca secures two positive regulatory opinions in Europe	21 Sept
Director dealings: Astrazeneca CEO raises stake	18 Sept
Deutsche Bank upgrades Astrazeneca to 'hold'	15 Sept
Astrazeneca's Etcamah trial fails to meet primary endpoint	14 Sept
AstraZeneca sees positive results from lung cancer drug trial	08 Sept
AstraZeneca's breast cancer drug granted accelerated approval in the US	07 Sept
AstraZeneca lifts lung‑cancer pipeline with Zegfrovy deal, Tagrisso data	01 Sept
Astrazeneca's Tezspire delivers positive results in EoE trial	27 Aug
AstraZeneca posts mixed lung‑cancer trial updates	17 Aug
AstraZeneca, Bristol Myers Squibb in talks over $400bn tie-up - report	03 Aug
AstraZeneca reports first-half growth, disappointment in Ultomiris trial	27 Jul
AstraZeneca breast cancer drug receives EU approval	23 Jul
Astrazeneca strikes exclusive licensing deal with Dizal Pharmaceutical	14 Jul
AstraZeneca shares slide on failure of cardiomyopathy trial	09 Jul
AstraZeneca's Datroway and Enhertu candidates receive EU approval	29 Jun
Astrazeneca secures US approval for Truqap combo in PTEN‑deficient prostate cancer	15 Jun
Astrazeneca's Imfinzi receives green light from US FDA	29 May
US FDA pushes back decision on Astrazeneca's camizestrant	27 May